2022-02-16 |
Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma |
Cancers. 2022 Feb 16;14(4):Article number 1005. |
 |
2022-02-15 |
Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1 |
American Journal of Cancer Research. 2022 Feb 15;12(2):713-728. |
 |
2022-02-11 |
Angiogenesis driven by the CEBPD–hsa-miR-429–VEGFA signaling axis promotes urothelial carcinoma progression |
Cells. 2022 Feb 11;11(4):Article number 638. |
 |
2022-02-10 |
Prediction model for pancreatic cancer—A population-based study from NHIRD |
Cancers. 2022 Feb 10;14(4):Article number 882. |
 |
2022-02-02 |
HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells |
Journal of Experimental and Clinical Cancer Research. 2022 Feb 2;41:Article number 47. |
 |
2022-02-01 |
A prediction model for tumor recurrence in stage II–III colorectal cancer patients: From a machine learning model to genomic profiling |
Biomedicines. 2022 Feb 1;10(2):Article number 340. |
 |
2022-02-01 |
Principle-based approach for the de-identification of code-mixed electronic health records |
IEEE Access. 2022 Feb;10:22875-22885. |
 |
2022-02-01 |
A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1 |
Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378. |
|
2022-02-01 |
A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma |
Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550. |
|
2022-02 |
Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan |
British Journal of Clinical Pharmacology. 2022 Jan;88(1):145-154. |
 |
2022-02 |
Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps |
Annals of Surgical Oncology. 2022 Feb;29(2):1130-1140. |
 |
2022-02 |
Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010) |
International Journal of Urology. 2022 Feb;29(2):121-127. |
 |
2022-02 |
Fracture risks in patients with atopic dermatitis: A nationwide matched cohort study—reply |
Annals of Allergy, Asthma and Immunology. 2022 Feb;128(2):Article number 231. |
 |
2022-02 |
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial |
Lancet Oncology. 2022 Feb;23(2):234-247. |
 |
2022-02 |
A portable controllable compressive stress device to monitor human breast cancer cell protrusions at single-cell resolution |
Frontiers in Bioengineering and Biotechnology. 2022 Feb;10:Article number 852318. |
 |
2022-02 |
Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors |
Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660. |
|
2022-02 |
What can the anti-apoptotic molecule, BIRC5/Survivin, do in the autophagic world? |
Cancer Science. 2022 Feb;113(S1):41. |
 |
2022-01-28 |
Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ |
PLoS ONE. 2022 Jan 28;17(1):Article number e0262934. |
 |
2022-01-11 |
Mortality and suicide related to major depressive disorder before and after type 2 diabetes mellitus |
Journal of Clinical Psychiatry. 2022 Jan 11;83(1):Article number 20m13692. |
 |
2022-01-11 |
Extracellular HSP90alpha induces MyD88-IRAK complex-associated IKKalpha/Beta−NF-KappaB/IRF3 and JAK2/TYK2−STAT-3 signaling in macrophages for tumor-promoting M2-polarization |
Cells. 2022 Jan 11;11(2):Article number 229. |
 |
2022-01-06 |
High level of aristolochic acid detected with a unique genomic landscape predicts early UTUC onset after renal transplantation in Taiwan |
Frontiers in Oncology. 2022 Jan 06;11:Article number 828314. |
 |
2022-01-05 |
Heterodimeric vascular endothelial growth factor and use thereof |
EP3384029/2022-01-05 |
|
2022-01 |
Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation |
Journal of the Formosan Medical Association. 2022 Jan;121(1 Pt 1):170-180. |
 |
2022-01 |
The "Dark Side" of autophagy on the maintenance of genome stability: Does it really exist during excessive activation? |
Journal of Cellular Physiology. 2022 Jan;237(1):178-188. |
 |
2022-01 |
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: Post hoc subanalysis from the ATTRACTION-2 study |
Gastric Cancer. 2022 Jan;25(1):207-217. |
 |